{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T09:24:36Z","timestamp":1794561876982,"version":"4.9.1"},"reference-count":117,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["ZIA HD009024"],"award-info":[{"award-number":["ZIA HD009024"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018101","name":"McKenna Claire Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018101","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ymgme.2026.110163","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T23:33:06Z","timestamp":1779147186000},"page":"110163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical and biochemical footprints of inherited cofactor disorders"],"prefix":"10.1016","volume":"148","author":[{"given":"Ivano","family":"Di Meo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos R.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Opladen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcnter","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Tiranti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"van Karnebeek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"van Walree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nenad","family":"Blau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2026.110163_bb0005","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1007\/s10545-008-0984-9","article-title":"Garrod\u2019s Croonian Lectures (1908) and the charter \u2018Inborn Errors of Metabolism\u2019: albinism, alkaptonuria, cystinuria, and pentosuria at age 100 in 2008","volume":"31","author":"Scriver","year":"2008","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2026.110163_bb0010","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1542\/pir.30.4.131","article-title":"Inborn errors of metabolism: part 1: overview","volume":"30","author":"Levy","year":"2009","journal-title":"Pediatr. Rev."},{"key":"10.1016\/j.ymgme.2026.110163_bb0015","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1542\/pir.30.4.e22","article-title":"Inborn errors of metabolism: Part 2: specific disorders","volume":"30","author":"Levy","year":"2009","journal-title":"Pediatr. Rev."},{"key":"10.1016\/j.ymgme.2026.110163_bb0020","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.08.021102","article-title":"Global birth prevalence and mortality from inborn errors of metabolism: a systematic analysis of the evidence","volume":"8","author":"Waters","year":"2018","journal-title":"J. Glob. Health"},{"key":"10.1016\/j.ymgme.2026.110163_bb0025","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/B978-0-444-64029-1.00022-9","article-title":"Inborn errors of metabolism","volume":"162","author":"Ferreira","year":"2019","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.ymgme.2026.110163_bb0030","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-023-02683-9","article-title":"Extending inherited metabolic disorder diagnostics with biomarker interaction visualizations","volume":"18","author":"Slenter","year":"2023","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2026.110163_bb0035","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41436-018-0022-8","article-title":"A proposed nosology of inborn errors of metabolism","volume":"21","author":"Ferreira","year":"2019","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2026.110163_bb0040","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/jimd.12348","article-title":"An international classification of inherited metabolic disorders (ICIMD)","volume":"44","author":"Ferreira","year":"2021","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2026.110163_bb0045","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-021-01727-2","article-title":"Treatable inherited metabolic disorders causing intellectual disability: 2021 review and digital app","volume":"16","author":"Hoytema van Konijnenburg","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2026.110163_bb0050","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1042\/BJ20110293","article-title":"Tetrahydrobiopterin: biochemistry and pathophysiology","volume":"438","author":"Werner","year":"2011","journal-title":"Biochem. J."},{"key":"10.1016\/j.ymgme.2026.110163_bb0055","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s10545-009-1067-2","article-title":"Disorders of biopterin metabolism","volume":"32","author":"Longo","year":"2009","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2026.110163_bb0060","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13023-020-01379-8","article-title":"Consensus guideline for the diagnosis and treatment of tetrahydrobiopterin (BH4) deficiencies","volume":"15","author":"Opladen","year":"2020","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2026.110163_bb0065","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ymgme.2021.04.003","article-title":"Molecular and metabolic bases of tetrahydrobiopterin (BH4) deficiencies","volume":"133","author":"Himmelreich","year":"2021","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110163_bb0070","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s10545-012-9506-x","article-title":"An international survey of patients with tetrahydrobiopterin deficiencies presenting with hyperphenylalaninaemia","volume":"35","author":"Opladen","year":"2012","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2026.110163_bb0075","series-title":"Sepiapterin reductase deficiency","author":"Friedman","year":"1993"},{"key":"10.1016\/j.ymgme.2026.110163_bb0080","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/BF00572762","article-title":"GTP cyclohydrolase I deficiency, a new enzyme defect causing hyperphenylalaninemia with neopterin, biopterin, dopamine, and serotonin deficiencies and muscular hypotonia","volume":"141","author":"Niederwieser","year":"1984","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgme.2026.110163_bb0085","series-title":"Childhood Basal Ganglia Disease with Remarkable Response to L-DOPA, Hereditary Basal Ganglia Disease With Marked Diurnal Fluctuation Shinryo (Tokyo)","first-page":"667","volume":"24","author":"Segawa","year":"1971"},{"key":"10.1016\/j.ymgme.2026.110163_bb0090","series-title":"Unconjugated Pterins and Related Biogenic Amines","first-page":"293","article-title":"6-Pyruvoyl-tetrahydropterin synthase deficiency: therapeutic trial with two different synthetic pterin analogues in three patients","author":"Leupold","year":"1987"},{"key":"10.1016\/j.ymgme.2026.110163_bb0095","series-title":"GeneReviews((R))","article-title":"PTS-related tetrahydrobiopterin deficiency (PTPSD)","author":"Opladen","year":"2025"},{"key":"10.1016\/j.ymgme.2026.110163_bb0100","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1086\/321970","article-title":"Mutations in the sepiapterin reductase gene cause a novel tetrahydrobiopterin-dependent monoamine neurotransmitter deficiency without hyperphenylalaninemia","volume":"69","author":"Bonaf\u00e9","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2026.110163_bb0105","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/BF03335415","article-title":"Primapterinuria: a new variant of atypical phenylketonuria","volume":"12","author":"Blau","year":"1989","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2026.110163_bb0110","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1681\/ASN.2013040337","article-title":"Mutations in PCBD1 cause hypomagnesemia and renal magnesium wasting","volume":"25","author":"Ferre","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ymgme.2026.110163_bb0115","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/S0140-6736(75)92498-8","article-title":"New variant of phenylketonuria with progressive neurological illness unresponsive to phenylalanine restriction","volume":"1","author":"Smith","year":"1975","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2026.110163_bb0120","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/jimd.12658","article-title":"Levodopa-refractory hyperprolactinemia and pituitary findings in inherited disorders of biogenic amine metabolism","volume":"47","author":"Yildiz","year":"2024","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2026.110163_bb0125","first-page":"204","article-title":"Cases of persistant hyperprolactinemia due to prolactinoma according to DHPR and PTPS deficiency","volume":"44","author":"Kobeyli","year":"2021","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2026.110163_bb0130","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28124713","article-title":"The history of mARC","volume":"28","author":"Clement","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.ymgme.2026.110163_bb0135","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.cbpa.2016.03.016","article-title":"Molybdenum cofactor and human disease","volume":"31","author":"Schwarz","year":"2016","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.ymgme.2026.110163_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27206896","article-title":"Molybdenum cofactor deficiency in humans","volume":"27","author":"Johannes","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ymgme.2026.110163_bb0145","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/jimd.12730","article-title":"Consensus guidelines for the diagnosis and management of isolated sulfite oxidase deficiency and molybdenum cofactor deficiencies","volume":"47","author":"Schwahn","year":"2024","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2026.110163_bb0150","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1214137","article-title":"A milder form of molybdenum cofactor deficiency type A presenting as Leigh\u2019s syndrome-like phenotype highlighting the secondary mitochondrial dysfunction: a case report","volume":"14","author":"Almudhry","year":"2023","journal-title":"Front. Neurol."},{"key":"10.1016\/j.ymgme.2026.110163_bb0155","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1002\/ajmg.a.38240","article-title":"Molybdenum cofactor deficiency: identification of a patient with homozygote mutation in the MOCS3 gene","volume":"173","author":"Huijmans","year":"2017","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.ymgme.2026.110163_bb0160","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3390\/molecules14010329","article-title":"Vitamin B6: a long known compound of surprising complexity","volume":"14","author":"Mooney","year":"2009","journal-title":"Molecules"},{"key":"10.1016\/j.ymgme.2026.110163_bb0165","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201708483","article-title":"Human ALPI deficiency causes inflammatory bowel disease and highlights a key mechanism of gut homeostasis","volume":"10","author":"Parlato","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymgme.2026.110163_bb0170","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/jimd.12060","article-title":"Disorders affecting vitamin B6 metabolism","volume":"42","author":"Wilson","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2026.110163_bb0175","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ymgme.2011.05.014","article-title":"Pyridoxine dependent epilepsy and antiquitin deficiency: clinical and molecular characteristics and recommendations for diagnosis, treatment and follow-up","volume":"104","author":"Stockler","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110163_bb0180","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1093\/brain\/awu051","article-title":"Epilepsy due to PNPO mutations: genotype, environment and treatment affect presentation and outcome","volume":"137","author":"Mills","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.ymgme.2026.110163_bb0185","series-title":"GeneReviews(\u00ae), University of Washington, Seattle Copyright \u00a9 1993\u20132025","article-title":"PLPBP Deficiency","author":"Al-Shekaili","year":"1993"},{"key":"10.1016\/j.ymgme.2026.110163_bb0190","series-title":"GeneReviews(\u00ae), University of Washington, Seattle Copyright \u00a9 1993\u20132025","article-title":"Pyridoxine-Dependent Epilepsy \u2013 ALDH7A1","author":"Gospe","year":"1993"},{"key":"10.1016\/j.ymgme.2026.110163_bb0195","series-title":"GeneReviews(\u00ae), University of Washington, Seattle Copyright \u00a9 1993\u20132025","article-title":"PNPO Deficiency","author":"Plecko","year":"1993"},{"key":"10.1016\/j.ymgme.2026.110163_bb0200","first-page":"3","article-title":"Early-onset vitamin B(6)-dependent epilepsy due to pathogenic PLPBP variants in a premature infant: a case report and review of the literature","volume":"58","author":"Heath","year":"2021","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymgme.2026.110163_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2024.107363","article-title":"Genotype and phenotype features and prognostic factors of neonatal-onset pyridoxine-dependent epilepsy: a systematic review","volume":"202","author":"Fang","year":"2024","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.ymgme.2026.110163_bb0210","first-page":"416","article-title":"Pyridoxine-dependent and pyridoxine-responsive seizures","volume":"43","author":"Baxter","year":"2001","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.ymgme.2026.110163_bb0215","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.pediatrneurol.2015.12.013","article-title":"Pyridoxine-dependent epilepsy: an expanding clinical spectrum","volume":"59","author":"van Karnebeek","year":"2016","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.ymgme.2026.110163_bb0220","doi-asserted-by":"crossref","DOI":"10.1186\/s13256-024-04876-7","article-title":"Late-onset drug-resistant epilepsy in pyridoxamine 5\u2032-phosphate oxidase deficiency: a case report","volume":"18","author":"Naghavi","year":"2024","journal-title":"J. Med. Case Rep."},{"key":"10.1016\/j.ymgme.2026.110163_bb0225","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci12010065","article-title":"Pyridoxine-dependent epilepsy and antiquitin deficiency resulting in neonatal-onset refractory seizures","volume":"12","author":"Kamini\u00f3w","year":"2021","journal-title":"Brain Sci."},{"key":"10.1016\/j.ymgme.2026.110163_bb0230","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/mdc3.13651","article-title":"Pyridoxine-dependent epilepsy: a treatable epilepsy syndrome presenting with dystonia and congenital cataracts with a novel mutation","volume":"10","author":"Saini","year":"2023","journal-title":"Mov. Disord. Clin. Pract."},{"key":"10.1016\/j.ymgme.2026.110163_bb0235","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jaapos.2013.01.006","article-title":"Congenital cataract in a child with pyridoxine-dependent epilepsy","volume":"17","author":"Yusuf","year":"2013","journal-title":"J. AAPOS."},{"key":"10.1016\/j.ymgme.2026.110163_bb0240","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/cge.13843","article-title":"Phenotypic and molecular spectrum of pyridoxamine-5\u2032-phosphate oxidase deficiency: a scoping review of 87 cases of pyridoxamine-5\u2032-phosphate oxidase deficiency","volume":"99","author":"Alghamdi","year":"2021","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ymgme.2026.110163_bb0245","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/jimd.12045","article-title":"The genotypic spectrum of ALDH7A1 mutations resulting in pyridoxine dependent epilepsy: a common epileptic encephalopathy","volume":"42","author":"Coughlin","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2026.110163_bb0250","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.913652","article-title":"Case report: PLPHP deficiency, a rare but important cause of B6-responsive disorders: a report of three novel individuals and review of 51 cases","volume":"13","author":"Alsubhi","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.ymgme.2026.110163_bb0255","article-title":"Pyridoxine-dependent epilepsy (PDE-ALDH7A1) in adulthood: a Dutch pilot study exploring clinical and patient-reported outcomes","volume":"31","author":"Tseng","year":"2022","journal-title":"Mol. Genet Metab. Rep."},{"key":"10.1016\/j.ymgme.2026.110163_bb0260","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1093\/brain\/awy346","article-title":"PLPHP deficiency: clinical, genetic, biochemical, and mechanistic insights","volume":"142","author":"Johnstone","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.ymgme.2026.110163_bb0265","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00198-023-06844-1","article-title":"Hypophosphatasia diagnosis: current state of the art and proposed diagnostic criteria for children and adults","volume":"35","author":"Khan","year":"2024","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.ymgme.2026.110163_bb0270","series-title":"GeneReviews(\u00ae), University of Washington, Seattle Copyright \u00a9 1993\u20132025","article-title":"Hypophosphatasia","author":"Dahir","year":"1993"},{"key":"10.1016\/j.ymgme.2026.110163_bb0275","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s12020-024-04054-1","article-title":"Diagnosis, treatment, and follow-up of patients with hypophosphatasia","volume":"87","author":"C\u00e1rdenas-Aguilera","year":"2025","journal-title":"Endocrine"},{"key":"10.1016\/j.ymgme.2026.110163_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2025.109046","article-title":"Genetic characterization of a large cohort of individuals with a clinical suspicion of hypophosphatasia in the United States","volume":"144","author":"Rush","year":"2025","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110163_bb0285","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/ana.25524","article-title":"PDXK mutations cause polyneuropathy responsive to pyridoxal 5\u2032-phosphate supplementation","volume":"86","author":"Chelban","year":"2019","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymgme.2026.110163_bb0290","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.nmd.2020.04.004","article-title":"Hereditary polyneuropathy with optic atrophy due to PDXK variant leading to impaired Vitamin B6 metabolism","volume":"30","author":"Keller","year":"2020","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymgme.2026.110163_bb0295","series-title":"Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease (Seventh Edition)","first-page":"859","article-title":"Chapter 48 - Disorders of pyridoxine metabolism","author":"Pena","year":"2025"},{"key":"10.1016\/j.ymgme.2026.110163_bb0300","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S0140-6736(94)90236-4","article-title":"Reduced GABA synthesis in pyridoxine-dependent seizures","volume":"343","author":"Gospe","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2026.110163_bb0305","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.ajhg.2016.10.011","article-title":"Mutations in PROSC disrupt cellular pyridoxal phosphate homeostasis and cause vitamin-B(6)-dependent epilepsy","volume":"99","author":"Darin","year":"2016","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2026.110163_bb0310","doi-asserted-by":"crossref","first-page":"e2627","DOI":"10.1212\/WNL.0000000000201222","article-title":"Association between lysine reduction therapies and cognitive outcomes in patients with pyridoxine-dependent epilepsy","volume":"99","author":"Coughlin","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2026.110163_bb0315","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1055\/a-2773-6076","article-title":"Hepatocellular carcinoma: a critical complication in patients treated with pyridoxal phosphate","volume":"57","author":"Brands","year":"2026","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.ymgme.2026.110163_bb0320","article-title":"Case report: hepatocellular carcinoma in a patient with Pyridoxamine 5-phosphate oxidase (PNPO) deficiency undergoing pyridoxal 5-phosphate (PLP) treatment","volume":"43","author":"Lee","year":"2025","journal-title":"Mol. Genet Metab. Rep."},{"key":"10.1016\/j.ymgme.2026.110163_bb0325","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1007\/s12325-025-03309-1","article-title":"Key learnings from clinical research and real-world evidence on asfotase alfa effectiveness in hypophosphatasia: 10 years post-approval","volume":"42","author":"Khan","year":"2025","journal-title":"Adv. Ther."},{"key":"10.1016\/j.ymgme.2026.110163_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2025.102728","article-title":"Targeting AASS alleviates neurotoxicity and improves mitochondrial function in astrocyte models for pyridoxine-dependent epilepsy","volume":"36","author":"Schuurmans","year":"2025","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymgme.2026.110163_bb0335","doi-asserted-by":"crossref","first-page":"fcaf397","DOI":"10.1093\/braincomms\/fcaf397","article-title":"New treatment for pyridoxine-dependent epilepsy due to ALDH7A1 deficiency: first proof-of-principle of upstream enzyme inhibition in the mouse","volume":"7","author":"van Karnebeek","year":"2025","journal-title":"Brain Commun."},{"key":"10.1016\/j.ymgme.2026.110163_bb0340","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1093\/jbmr\/zjaf136","article-title":"ENPP1 inhibition as a therapeutic approach for later-onset hypophosphatasia","volume":"41","author":"Narisawa","year":"2025","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.ymgme.2026.110163_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2024.109002","article-title":"Feasibility of newborn screening for pyridoxine-dependent epilepsy","volume":"144","author":"Pauly","year":"2025","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110163_bb0350","article-title":"A case for newborn screening for pyridoxine-dependent epilepsy","volume":"8","author":"Coughlin","year":"2022","journal-title":"Cold Spring Harb. Mol. Case Stud."},{"key":"10.1016\/j.ymgme.2026.110163_bb0355","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1515\/cclm-2024-1230","article-title":"Inclusion of pyridoxine dependent epilepsy in expanded newborn screening programs by tandem mass spectrometry: set up of first and second tier tests","volume":"63","author":"Damiano","year":"2025","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.ymgme.2026.110163_bb0360","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cmet.2015.05.023","article-title":"NAD(+) metabolism and the control of energy homeostasis: a balancing act between mitochondria and the nucleus","volume":"22","author":"Canto","year":"2015","journal-title":"Cell Metab."},{"key":"10.1016\/j.ymgme.2026.110163_bb0365","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/s41392-020-00311-7","article-title":"NAD(+) metabolism: pathophysiologic mechanisms and therapeutic potential","volume":"5","author":"Xie","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ymgme.2026.110163_bb0370","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1056\/NEJMoa1616361","article-title":"NAD deficiency, congenital malformations, and niacin supplementation","volume":"377","author":"Shi","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2026.110163_bb0375","series-title":"GeneReviews((R))","article-title":"Congenital NAD deficiency disorder","author":"Mark","year":"1993"},{"key":"10.1016\/j.ymgme.2026.110163_bb0380","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/ajmg.a.38602","article-title":"Collaborators of, Clinical heterogeneity of mitochondrial NAD kinase deficiency caused by a NADK2 start loss variant","volume":"176","author":"Pomerantz","year":"2018","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.ymgme.2026.110163_bb0385","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.1182\/blood.2025030958","article-title":"NMNAT3 deficiency: a novel red blood cell enzymopathy causing hemolysis by altering NAD levels and glycolysis","volume":"146","author":"Ruiter","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2026.110163_bb0390","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/jimd.12541","article-title":"Clinical and biochemical distinctions for a metabolite repair disorder caused by NAXD or NAXE deficiency","volume":"45","author":"Van Bergen","year":"2022","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2026.110163_bb0395","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/ng.2356","article-title":"Mutations in NMNAT1 cause Leber congenital amaurosis and identify a new disease pathway for retinal degeneration","volume":"44","author":"Koenekoop","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymgme.2026.110163_bb0400","doi-asserted-by":"crossref","first-page":"5009","DOI":"10.1093\/hmg\/ddu218","article-title":"Mitochondrial NADP(H) deficiency due to a mutation in NADK2 causes dienoyl-CoA reductase deficiency with hyperlysinemia","volume":"23","author":"Houten","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2026.110163_bb0405","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ymgme.2022.04.003","article-title":"NAXE deficiency: a neurometabolic disorder of NAD(P)HX repair amenable for metabolic correction","volume":"136","author":"Manor","year":"2022","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110163_bb0410","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12610-022-00176-6","article-title":"Testicular impairment in primary adrenal insufficiency caused by nicotinamide nucleotide transhydrogenase (NNT) deficiency - a case report: implication of oxidative stress and importance of fertility preservation","volume":"33","author":"Ferreux","year":"2023","journal-title":"Basic Clin. Androl."},{"key":"10.1016\/j.ymgme.2026.110163_bb0415","doi-asserted-by":"crossref","first-page":"14796","DOI":"10.1074\/jbc.M114.554378","article-title":"Deficiency of nicotinamide mononucleotide adenylyltransferase 3 (nmnat3) causes hemolytic anemia by altering the glycolytic flow in mature erythrocytes","volume":"289","author":"Hikosaka","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2026.110163_bb0420","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1038\/ng.2361","article-title":"NMNAT1 mutations cause Leber congenital amaurosis","volume":"44","author":"Falk","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymgme.2026.110163_bb0425","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.ajhg.2016.07.018","article-title":"NAXE mutations disrupt the cellular NAD(P)HX repair system and cause a lethal neurometabolic disorder of early childhood","volume":"99","author":"Kremer","year":"2016","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2026.110163_bb0430","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2024.1204848","article-title":"Long-term follow-up of an attenuated presentation of NAXE-related disease, a potentially actionable neurometabolic disease: a case report","volume":"15","author":"Almudhry","year":"2024","journal-title":"Front. Neurol."},{"key":"10.1016\/j.ymgme.2026.110163_bb0435","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.21037\/tp-24-476","article-title":"Metabolic cardiomyopathy associated with a compound heterozygous variant in NAD(P)HX dehydratase: a case report and literature review","volume":"13","author":"Mo","year":"2024","journal-title":"Transl. Pediatr."},{"key":"10.1016\/j.ymgme.2026.110163_bb0440","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1530\/EJE-16-0056","article-title":"NNT mutations: a cause of primary adrenal insufficiency, oxidative stress and extra-adrenal defects","volume":"175","author":"Roucher-Boulez","year":"2016","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ymgme.2026.110163_bb0445","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ajhg.2019.12.006","article-title":"Bi-allelic mutations in NADSYN1 cause multiple organ defects and expand the genotypic spectrum of congenital NAD deficiency disorders","volume":"106","author":"Szot","year":"2020","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2026.110163_bb0450","doi-asserted-by":"crossref","DOI":"10.1172\/JCI174824","article-title":"A metabolic signature for NADSYN1-dependent congenital NAD deficiency disorder","volume":"134","author":"Szot","year":"2024","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2026.110163_bb0455","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/cge.14328","article-title":"Clinical heterogeneity of NADSYN1-associated VCRL syndrome","volume":"104","author":"Aubert-Mucca","year":"2023","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ymgme.2026.110163_bb0460","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-4534","article-title":"Lysine restriction and pyridoxal phosphate administration in a NADK2 patient","volume":"138","author":"Tort","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2026.110163_bb0465","doi-asserted-by":"crossref","DOI":"10.3390\/genes13050717","article-title":"Long-term follow-up of three family members with a novel NNT pathogenic variant causing primary adrenal insufficiency","volume":"13","author":"Krasovec","year":"2022","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.ymgme.2026.110163_bb0470","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.plipres.2005.04.001","article-title":"Coenzyme A: back in action","volume":"44","author":"Leonardi","year":"2005","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.ymgme.2026.110163_bb0475","doi-asserted-by":"crossref","DOI":"10.1128\/ecosalplus.3.6.3.4","article-title":"Biosynthesis of pantothenic acid and Coenzyme A","volume":"2","author":"Leonardi","year":"2007","journal-title":"EcoSal Plus"},{"key":"10.1016\/j.ymgme.2026.110163_bb0480","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24065951","article-title":"Inherited disorders of Coenzyme A biosynthesis: models, mechanisms, and treatments","volume":"24","author":"Cavestro","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymgme.2026.110163_bb0485","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/cns.13294","article-title":"Natural history and genotype-phenotype correlation of pantothenate kinase-associated neurodegeneration","volume":"26","author":"Chang","year":"2020","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.ymgme.2026.110163_bb0490","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.bbadis.2011.06.016","article-title":"Neurodegeneration with brain iron accumulation - clinical syndromes and neuroimaging","volume":"1822","author":"Schipper","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2026.110163_bb0495","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ymgme.2022.09.011","article-title":"PKAN pathogenesis and treatment","volume":"137","author":"Hayflick","year":"2022","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110163_bb0500","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/jimd.12584","article-title":"Pathogenic variants of the Coenzyme A biosynthesis-associated enzyme phosphopantothenoylcysteine decarboxylase cause autosomal-recessive dilated cardiomyopathy","volume":"46","author":"Bravo-Alonso","year":"2023","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2026.110163_bb0505","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.ajhg.2018.03.022","article-title":"Mutations in PPCS, encoding phosphopantothenoylcysteine synthetase, cause autosomal-recessive dilated cardiomyopathy","volume":"102","author":"Iuso","year":"2018","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2026.110163_bb0510","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1002\/ajmg.a.62848","article-title":"Novel phosphopantothenoylcysteine synthetase (PPCS) mutations with prominent neuromuscular features: expanding the phenotypical spectrum of PPCS-related disorders","volume":"188","author":"Lok","year":"2022","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.ymgme.2026.110163_bb0515","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/s43856-025-01017-z","article-title":"Pantethine ameliorates dilated cardiomyopathy features in PPCS deficiency disorder in patients and cell line models","volume":"5","author":"Zhang","year":"2025","journal-title":"Commun. Med."},{"key":"10.1016\/j.ymgme.2026.110163_bb0520","first-page":"75","article-title":"SLC25A42-associated mitochondrial encephalomyopathy: report of additional founder cases and functional characterization of a novel deletion","volume":"60","author":"Aldosary","year":"2021","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymgme.2026.110163_bb0525","first-page":"417","article-title":"Expanding the genetic and clinical spectrum of SLC25A42-associated disorders and testing of pantothenic acid to improve CoA level in vitro","volume":"65","author":"Heckmann","year":"2024","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymgme.2026.110163_bb0530","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ajhg.2013.11.008","article-title":"Exome sequence reveals mutations in CoA synthase as a cause of neurodegeneration with brain iron accumulation","volume":"94","author":"Dusi","year":"2014","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2026.110163_bb0535","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1002\/acn3.52079","article-title":"Emerging variants, unique phenotypes, and transcriptomic signatures: an integrated study of COASY-associated diseases","volume":"11","author":"Cavestro","year":"2024","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.ymgme.2026.110163_bb0540","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1002\/ajmg.a.38252","article-title":"Diagnosis of CoPAN by whole exome sequencing: waking up a sleeping tiger\u2019s eye","volume":"173","author":"Evers","year":"2017","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.ymgme.2026.110163_bb0545","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1038\/s41431-018-0233-0","article-title":"Biallelic loss of function variants in COASY cause prenatal onset pontocerebellar hypoplasia, microcephaly, and arthrogryposis","volume":"26","author":"van Dijk","year":"2018","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2026.110163_bb0550","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41421-023-00641-0","article-title":"COASY variant as a new genetic cause of riboflavin-responsive lipid storage myopathy","volume":"10","author":"Zheng","year":"2024","journal-title":"Cell Discov."},{"key":"10.1016\/j.ymgme.2026.110163_bb0555","doi-asserted-by":"crossref","first-page":"18152","DOI":"10.1074\/jbc.M109.014118","article-title":"A novel member of solute carrier family 25 (SLC25A42) is a transporter of coenzyme A and adenosine 3\u2032,5\u2032-diphosphate in human mitochondria","volume":"284","author":"Fiermonte","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2026.110163_bb0560","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci11081031","article-title":"Coenzyme A biochemistry: from neurodevelopment to neurodegeneration","volume":"11","author":"Mignani","year":"2021","journal-title":"Brain Sci."},{"key":"10.1016\/j.ymgme.2026.110163_bb0565","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.629414","article-title":"Emerging disease-modifying therapies in neurodegeneration with brain iron accumulation (NBIA) disorders","volume":"12","author":"Iankova","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/j.ymgme.2026.110163_bb0570","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2024.106977","article-title":"Illustration of the long-term efficacy of pallidal deep brain stimulation in a patient with PKAN dystonia","volume":"123","author":"Romito","year":"2024","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.ymgme.2026.110163_bb0575","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S1474-4422(19)30142-5","article-title":"Safety and efficacy of deferiprone for pantothenate kinase-associated neurodegeneration: a randomised, double-blind, controlled trial and an open-label extension study","volume":"18","author":"Klopstock","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ymgme.2026.110163_bb0580","article-title":"Open-label Fosmetpantotenate, a phosphopantothenate replacement therapy in a single patient with atypical PKAN","volume":"2017","author":"Christou","year":"2017","journal-title":"Case Rep. Neurol. Med."},{"key":"10.1016\/j.ymgme.2026.110163_bb0585","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1002\/ehf2.15283","article-title":"Pantethine therapy dramatically rescues end-stage failing heart in a patient with deficiency of coenzyme A biosynthesis","volume":"12","author":"Goetz","year":"2025","journal-title":"ESC Heart Fail."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719226004464?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719226004464?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T08:24:05Z","timestamp":1794558245000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719226004464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":117,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1096719226004464"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2026.110163","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and biochemical footprints of inherited cofactor disorders","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2026.110163","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110163"}}